GVHD
GVHD
Advertisement
Dustin SamplesGVHD | May 17, 2023
In one murine study, donor T cells appeared to maintain a progenitor-like population in GVHD-affected tissue.
Read More
Dustin SamplesGVHD | May 17, 2023
Erythema body surface area kept its total prognostic information on NRM and OS longer than the NIH scoring system.
Elaine S. DeMeyer, RN, MSN, AOCN®, BMTCN®GVHD | May 15, 2023
Oncology nurses must help to screen and assess for the clinical manifestations of scalp or body hair changes with cGVHD.
Elaine S. DeMeyer, RN, MSN, AOCN®, BMTCN®GVHD | May 15, 2023
Though enteral nutrition appears to lead to better outcomes than total parenteral nutrition, guidelines are lacking for GVHD.
Elaine S. DeMeyer, RN, MSN, AOCN®, BMTCN®GVHD | April 19, 2023
A balanced microbiome can lead to improved outcomes, but how can the gut microbiome be regulated?
Elaine S. DeMeyer, RN, MSN, AOCN®, BMTCN®GVHD | April 19, 2023
There is more to consider when caring for patients with chronic graft-versus-host disease than just the physical effects.
Dustin SamplesGVHD | April 19, 2023
A single-center study demonstrated good results with the trio of PT-Cy, tacrolimus, and low-dose anti-thymocyte globulin.
Dustin SamplesGVHD | April 19, 2023
Exosomes, T regulatory cells, and myeloid-derived-suppressor-cells could be the future of GVHD prevention.
Elaine S. DeMeyer, RN, MSN, AOCN®, BMTCN®GVHD | March 29, 2023
Graft-versus-host disease is the most life-threatening consequence of stem cell transplant, and nurses are urgently needed.
Elaine S. DeMeyer, RN, MSN, AOCN®, BMTCN®GVHD | March 29, 2023
The benefits of mindfulness meditation are numerous and far-reaching. But can they help HSCT recipients with GVHD?
Dustin SamplesGVHD | March 29, 2023
Certain species were predictive of not only the occurrence of GVHD, but also the severity.
Dustin SamplesGVHD | March 29, 2023
Pruritus is considered a mild adverse event, but does it negatively affect quality of life?
Elaine S. DeMeyer, RN, MSN, AOCN®, BMTCN®Best Practices | March 8, 2023
Many patients don't have a plan for returning to work. You can help them make a plan and adapt to changes along the way.
Elaine S. DeMeyer, RN, MSN, AOCN®, BMTCN®Best Practices | March 8, 2023
Do you know how to assess for gut GVHD? This article covers assessment, pathobiology, and staging.
Elaine S. DeMeyer, RN, MSN, AOCN®, BMTCN®Best Practices | March 8, 2023
In patients with GVHD, some forms of grief are expected and accepted, yet others go unrecognized.
Elaine S. DeMeyer, RN, MSN, AOCN®, BMTCN®Best Practices | March 8, 2023
Using these 3 strategies, you can build your resiliency to benefit yourself and your patients.
Dustin SamplesConferences | February 21, 2023
Continuous intravenous tacrolimus administration can be logistically challenging. Can intermittent dosing work as well?
Dustin SamplesGVHD | February 16, 2023
Vascular access events caused most patients to discontinue treatment. Does catheter type affect event frequency?
Dustin SamplesGVHD | February 16, 2023
Can extracorporeal photopheresis treat acute graft-versus-host disease when the disease has become steroid dependent?
Dustin SamplesGVHD | February 15, 2023
The accepted belief is that late-onset acute GVHD is less severe, but one study demonstrated the opposite.
Advertisement
Advertisement
Advertisement